All In MedTech

Device Trial Radar · NCT02357381

eNeura SpringTMS Post-Market Observational US Study of Migraine

eNeura SpringTMS Post-Market Observational U.S. Study of Migraine

Last checked: Nov 20, 2026Latest source record: Jun 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

263

Actual

Start

Dec 1, 2014

Primary completion

Jul 1, 2016

Study completion Jul 1, 2016

Sponsor

Lead sponsor
eNeura, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 6, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multi-center, prospective, non-randomized, single arm, open label, post-market, observational study to evaluate the use of the eneura, springtms system in reduction of migraine headache symptoms.

Conditions

  • Headache

Interventions

  • eNeura SpringTMSDevice

    Single pulse magnetic stimulation for prevention and/or treatment of migraine headache with or without aura.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Headache DaysTime frame: 3 months

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Phoenix, Arizona

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.